简体
简体中文
繁體中文

Market Vectors Colombia ETF COLX

等待开盘 09-17 09:30:00 美东时间

0.00

0.000

NaN.00%

华盛通华盛通
立即下载
  • 最 高--
  • 今 开--
  • 成交量 0股
  • 最 低 --
  • 昨 收 0.00
  • 总市值 0
  • 52周最高 0.00
  • 市盈率 --
  • 换手率 NaN.00%
  • 52周最低 0.00
  • 委 比 0.00%
  • 总股本 --
  • 历史最高 0.00
  • 量 比 0
  • 振 幅 NaN.00%
  • 历史最低 0.00
  • 每 手 1
  • 风险率

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting

    Collegium Pharmaceutical, Inc. will present nine posters at PAINWeek 2025, highlighting real-world data from its pain portfolio, including BELBUCA and XTAMPZA ER. The posters aim to provide insights for healthcare professionals and reflect the company's commitment to responsible pain management. The session will take place on September 4, 2025, in Las Vegas.

    08-25 12:00

  • Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025

    Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced it will report second quarter 2025 financial results before the market opens on Thursday, August 7, 2025. A live conference call and webcast will be held at 8:00 a.m. ET. Investors can join via phone at (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference "Collegium Pharmaceutical Q2 2025 Earnings Call." The webcast will be available on the Company’s website at www.collegium...

    07-24 12:00

  • Collegium Announces $150 Million Share Repurchase Program

    Collegium Pharmaceutical, Inc. announced a new $150 million stock repurchase program through December 31, 2026, replacing a previous program that expired with $65 million remaining. The company has returned $222 million to shareholders since 2021 and currently has 32.1 million shares outstanding.

    07-07 12:00